TAKEDA PHARMACEUTIC-SP ADR (TAK) Earnings History & Surprises

NYSE:TAK • US8740602052

Current stock price

17.85 USD
+0.03 (+0.17%)
At close:
17.85 USD
0 (0%)
After Hours:

TAK Earnings overview

Past quarterly earnings results for TAKEDA PHARMACEUTIC-SP ADR (TAK), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
May 13, 2026
Period
Q4 / 2026
EPS Estimate
-¥12
Revenue Estimate
1.132T

Last Reported

Most Recent
Release Date
Jan 30, 2026
Period
Q3 / 2026
EPS Reported
¥33
EPS Surprise
90.61%
Revenue Surprise
0.21%

Beat Rate

Last 8 Quarters
50%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in JPY): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q3 2026 32.81 17.21 90.61% 341.77% 1.192T 1.189T 0.21% 4.16%
Q2 2026 -3.74 17.06 -121.92% -112.87% 1.113T 1.184T -6.04% -5.38%
Q1 2026 39.68 28.56 38.94% 30.79% 1.107T 1.187T -6.76% -8.39%
Q4 2025 -32.66 -27.88 -17.13% -3,151.24% 1.053T 1.076T -2.10% 0.24%
Q3 2025 7.43 12.71 -41.58% -78.01% 1.144T 1.15T -0.48% 2.96%
Q2 2025 29.05 16.56 75.50% 287.55% 1.176T 1.106T 6.35% 12.75%
Q1 2025 30.34 22.09 37.34% 5.56% 1.208T 1.104T 9.45% 14.11%
Q4 2024 -1.00 0.39 -357.78% -110.03% 1.051T 916.958B 14.60% 9.91%
Q3 2024 33.78 14.38 134.84% -11.88% 1.111T 1.017T 9.24% 1.33%
Q2 2024 -15.49 18.39 -184.23% -177.99% 1.043T 1.009T 3.34% 4.07%
Q1 2024 28.74 34.92 -17.69% -15.35% 1.059T 992.223B 6.69% 8.86%
Q4 2023 10.01 6.78 47.57% 388.22% 956.156B 966.415B -1.06% 9.49%
Q3 2023 38.33 37.62 1.89% 107.24% 1.097T 1.015T 8.05% 21.66%
Q2 2023 19.86 19.30 2.91% 35.93% 1.002T 962.035B 4.19% 18.64%
Q1 2023 33.95 35.90 -5.43% -22.76% 972.465B 934.47B 4.07% 2.41%
Q4 2022 -3.47 3.01 -215.36% -105.51% 873.289B 847.458B 3.05% 13.37%
Q3 2022 18.50 25.53 -27.54% -37.36% 901.294B 846.517B 6.47% 7.71%
Q2 2022 14.61 23.87 -38.79% 1,229.27% 844.82B 825.266B 2.37% 7.08%
Q1 2022 43.96 33.97 29.40% 66.19% 949.603B 873.46B 8.72% 18.43%
Q4 2021 63.01 24.19 160.51% 11,362.22% 770.274B 791.881B -2.73% -0.19%
Q3 2021 29.53 21.90 34.83% 886.43% 836.753B 847.525B -1.27% -2.63%
Q2 2021 1.10 16.43 -93.31% -93.64% 788.935B 840.261B -6.11% -2.73%
Q1 2021 26.45 8.10 226.72% 498.57% 801.85B 814.274B -1.53% -5.57%
Q4 2020 0.55 -53.07 101.04% - 771.702B 802.131B -3.79% -
Q3 2020 2.99 -15.27 119.60% - 859.317B 844.174B 1.79% -
Q2 2020 17.29 -23.52 173.52% - 811.048B 822.735B -1.42% -
Q1 2020 -6.64 -21.96 69.77% - 849.121B 824.716B 2.96% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

TAK EPS Q2Q GrowthTAK EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 Q1/27 0 5K 10K

Revenue Historical Q2Q growth and Acceleration

TAK Revenue Q2Q GrowthTAK Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 Q1/27 0 10 20

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
2
Average EPS beat (4)
-2.37%
Max EPS beat (4)
90.61%
Min EPS beat (4)
-121.92%

Revenue beat statistics

Revenue beat (4)
1
Average Revenue beat (4)
-3.67%
Max Revenue beat (4)
0.21%
Min Revenue beat (4)
-6.76%

Analysis

In the last 4 quarters, TAK has beaten EPS estimates in 2 out of 4 releases
TAK has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, TAK reported -2.4% below the EPS estimates on average.
In the last 4 quarters, TAK reported -3.7% below the revenue estimates on average.
TAK Overview TAK Technical Analysis Report TAK Fundamental Analysis Report TAK Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

TAKEDA PHARMACEUTIC-SP ADR / TAK Earnings FAQ

What is the most recent earnings date for TAK stock?

TAKEDA PHARMACEUTIC-SP ADR (TAK) last reported earnings on 1/30/2026.

Did TAK stock beat earnings estimates in the most recent quarter?

TAKEDA PHARMACEUTIC-SP ADR (TAK) beat EPS estimates and beat revenue estimates in the most recent quarter.

How often does TAKEDA PHARMACEUTIC-SP ADR (TAK) beat earnings estimates?

In the last 4 quarters, TAKEDA PHARMACEUTIC-SP ADR (TAK) has beaten EPS estimates in 2 out of 4 releases.